Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

4.2%

1 terminated/withdrawn out of 24 trials

Success Rate

93.3%

+6.8% vs industry average

Late-Stage Pipeline

33%

8 trials in Phase 3/4

Results Transparency

7%

1 of 14 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

N/A
8(36.4%)
Phase 3
4(18.2%)
Phase 4
4(18.2%)
Phase 1
3(13.6%)
Phase 2
3(13.6%)
22Total
N/A(8)
Phase 3(4)
Phase 4(4)
Phase 1(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT05913479Not ApplicableCompleted

Evaluation of the Efficacy and Safety of Mucogye® Gel as a Moisturizer

Role: lead

NCT06568588Phase 2Active Not Recruiting

Effects of Probiotic Consumption in Children With Autism Spectrum Disorder (ASD)

Role: collaborator

NCT07212907Not ApplicableRecruiting

Probiotic and Ginger Supplement for Symptoms and Quality of Life in Functional Dyspepsia (SUBTILE)

Role: lead

NCT07168434Phase 3Recruiting

Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome

Role: lead

NCT07176832Phase 1Completed

Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ)

Role: lead

NCT05735951Phase 1Completed

Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function

Role: lead

NCT06451913Phase 4Recruiting

Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))

Role: lead

NCT06282614Not ApplicableTerminated

Performance and Safety of MUCOGYNE® Ovule as a Moisturizer

Role: lead

NCT06585579Not ApplicableNot Yet Recruiting

The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)

Role: lead

NCT05544058Completed

Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA

Role: lead

NCT05419180Phase 4Completed

Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies

Role: lead

NCT06465472Phase 3Not Yet Recruiting

Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3

Role: lead

NCT05888194Not ApplicableRecruiting

The Effect of Mucogyne® Gel on Wound Healing

Role: lead

NCT05273333Not ApplicableUnknown

Effect of Ultra-gyn® on Vulvovaginal Candidiasis

Role: lead

NCT04786938Phase 4Completed

Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy

Role: collaborator

NCT03819647Phase 2Completed

Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria

Role: lead

NCT04662502Completed

Efficacy of Bifidobacterium Longum 35624 on the Quality of Life of IBS Patients With Different Symptom Severity

Role: lead

NCT03866928Phase 1Completed

Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers

Role: lead

NCT03539913Phase 4Completed

Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in Children

Role: lead

NCT02250729Not ApplicableUnknown

Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure

Role: collaborator